Medifast Forecasts 45.2% Fiscal Earnings Growth Despite Four Quarter Misses
Medifast carries a Zacks Rank #2 with the consensus estimate forecasting 45.2% earnings growth for the current fiscal year. The company has missed earnings estimates by a sharp margin in each of the past four quarters.
1. Zacks Ranking and Growth Forecast
Medifast holds a Zacks Rank #2 rating and the consensus estimate projects a 45.2% increase in fiscal year earnings compared to the prior year, reflecting strong expected demand for its healthy living products and programs.
2. Consecutive Quarterly Earnings Misses
The company has underperformed consensus in four straight quarters, missing earnings estimates by a significant margin, which may signal execution challenges or softer-than-expected consumer spending ahead of the anticipated growth period.
Related News
NVDA
NVIDIA Forecasts Zero China Data Center Revenue, Targets $20B Vera CPU Sales
NVDA•
SLAB
Silicon Labs SoC Powers 500,000 Wi-SUN Module Shipment for India Grid
SLAB•
JEPQ
JPMorgan ETF Offers 9.5% Yield with Hidden ELN Counterparty Risk
JEPQ•
NVDA
Nvidia Q2 Profit Jumps 200% with Revenue Up 85%
NVDA•
MSFT
Microsoft’s AI Spending Drives 50% of Nvidia’s $38 B Data Center Revenue
MSFT•
Sources
F